Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May:117:103732.
doi: 10.1016/j.jbi.2021.103732. Epub 2021 Mar 16.

Search and visualization of gene-drug-disease interactions for pharmacogenomics and precision medicine research using GeneDive

Affiliations

Search and visualization of gene-drug-disease interactions for pharmacogenomics and precision medicine research using GeneDive

Mike Wong et al. J Biomed Inform. 2021 May.

Abstract

Background: Understanding the relationships between genes, drugs, and disease states is at the core of pharmacogenomics. Two leading approaches for identifying these relationships in medical literature are: human expert led manual curation efforts, and modern data mining based automated approaches. The former generates small amounts of high-quality data, and the latter offers large volumes of mixed quality data. The algorithmically extracted relationships are often accompanied by supporting evidence, such as, confidence scores, source articles, and surrounding contexts (excerpts) from the articles, that can be used as data quality indicators. Tools that can leverage these quality indicators to help the user gain access to larger and high-quality data are needed.

Approach: We introduce GeneDive, a web application for pharmacogenomics researchers and precision medicine practitioners that makes gene, disease, and drug interactions data easily accessible and usable. GeneDive is designed to meet three key objectives: (1) provide functionality to manage information-overload problem and facilitate easy assimilation of supporting evidence, (2) support longitudinal and exploratory research investigations, and (3) offer integration of user-provided interactions data without requiring data sharing.

Results: GeneDive offers multiple search modalities, visualizations, and other features that guide the user efficiently to the information of their interest. To facilitate exploratory research, GeneDive makes the supporting evidence and context for each interaction readily available and allows the data quality threshold to be controlled by the user as per their risk tolerance level. The interactive search-visualization loop enables relationship discoveries between diseases, genes, and drugs that might not be explicitly described in literature but are emergent from the source medical corpus and deductive reasoning. The ability to utilize user's data either in combination with the GeneDive native datasets or in isolation promotes richer data-driven exploration and discovery. These functionalities along with GeneDive's applicability for precision medicine, bringing the knowledge contained in biomedical literature to bear on particular clinical situations and improving patient care, are illustrated through detailed use cases.

Conclusion: GeneDive is a comprehensive, broad-use biological interactions browser. The GeneDive application and information about its underlying system architecture are available at http://www.genedive.net. GeneDive Docker image is also available for download at this URL, allowing users to (1) import their own interaction data securely and privately; and (2) generate and test hypotheses across their own and other datasets.

Keywords: Biomedical information retrieval; Gene interactions; Gene sets; Gene-disease and gene-drug relationships; Retrieval and visualization.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests

The authors declare that there is no conflict of interest.

Figures

Figure 1:
Figure 1:
GeneDive architecture diagram showing data sources and workflow.
Figure 2:
Figure 2:
GeneDive Application State Diagram showing application states and transitions.
Figure 3:
Figure 3:
Search results for NOD2 gene with a confidence score of 0.85, showing references to genes related to immune response.
Figure 4:
Figure 4:
Comparison of partial network overlap of two gene sets. (a) Search results for genes in Type 2 diabetes mellitus pathway set and in insulin signaling pathway set. Multiple genes exist in both sets, indicated by two-colored nodes. (b) Search results for genes in Type 1 diabetes mellitus pathway set and in insulin signaling pathway set. No genes exist in both sets, indicated by single colored nodes.
Figure 4:
Figure 4:
Comparison of partial network overlap of two gene sets. (a) Search results for genes in Type 2 diabetes mellitus pathway set and in insulin signaling pathway set. Multiple genes exist in both sets, indicated by two-colored nodes. (b) Search results for genes in Type 1 diabetes mellitus pathway set and in insulin signaling pathway set. No genes exist in both sets, indicated by single colored nodes.
Figure 5:
Figure 5:
GeneDive provides link-outs to appropriate NCBI and PharmGKB resource pages for convenient referencing.
Figure 6:
Figure 6:
The search results for ‘abacavir’ and ‘HLA-B’, with highlight on ‘57:01 allele’ reveals the risk of patient’s hypersensitivity to abacavir.
Figure 7:
Figure 7:
The search results for ‘atazanavir’ and ‘UGT1A1’, with filter on Excerpts for ‘allele’ reveals the risk of patient developing jaundice.
Figure 8:
Figure 8:
The search results for ‘ribavirin’ filtered on Excerpts for ‘coinfect
Figure 9:
Figure 9:
The tabular view reveals the optimum dosage of azathioprine and its methylation by TPMT.
Figure 10:
Figure 10:
Visualizing BioGrid’s COVID-19 interaction data with native GeneDive data sources using low confidence for broad exploration

References

    1. Mooney S, Progress towards the integration of pharmacogenomics in practice, Hum Genet 134 (5) (2015) 459–465. - PMC - PubMed
    1. RellingV M, Evans W, Pharmacogenomics in the clinic, Nature 526 (2015) 343–350. - PMC - PubMed
    1. Lee J, Aminkeng F, Bhavsar A, et al., The emerging era of pharmacogenomics: current successes, future potential, and challenges, Clin Genet 86 (1) (2014) 21–28. - PMC - PubMed
    1. Thorn C, Klein T, Altman R, Pharmacogenomics and bioinformatics: Pharmgkb, Pharmacogenomics 11 (4) (2010) 501–505. - PMC - PubMed
    1. Samwald M, Coulet A, Huerga I, et al., Semantically enabling pharmacogenomic data for the realization of personalized medicine, Pharmacogenomics 13 (2) (2012) 201–2102. - PMC - PubMed

Publication types

Substances